Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) - From Preclinical Studies to a Clinical Phase II Trial. Specht HM1, Ahrens N2, Blankenstein C3, Duell T4, Fietkau R5, Gaipl US5, Günther C6, Gunther S1, Habl G1, Hautmann H7, Hautmann M8, Huber RM9, Molls M1, Offner R2, Rödel C10, Rödel F10, Schütz M11, Combs SE1, Multhoff G12.
^ Gong J, Maki G, Klingemann H. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells.
Zhang, H. et al. Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells. J. Immunother. 34, 187–195 (2011).